QIAGEN N.V. Annual Report 2001

QIAGEN N.V. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY AND COMPREHENSIVE INCOME
Common Shares
Shares Amount
Additional
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Total
Shareholders’
Equity
32
BALANCE AT
DECEMBER 31,
1998
139,888,291
Net income
–
Unrealized loss, net
on marketable securities
–
Translation adjustment
–
Comprehensive income
–
Conversion of par value
to EUR 0.01
–
Exercise of stock options 926,772
Tax benefit in connection
with nonqualified
stock options
–
BALANCE AT
DECEMBER 31,
1999
140,815,063
Net income
–
Unrealized gain, net
on marketable securities
–
Translation adjustment
–
Comprehensive income
–
Exercise of stock options 1,117,424
Private placement
of common stock 616,000
Finders’ fees paid by
Operon shareholders
–
Tax benefit in connection
with nonqualified
stock options
–
BALANCE AT
DECEMBER 31,
2000
142,548,487
Net income
–
Unrealized loss, net
on marketable securities
–
Realized gain, net
on marketable securities
–
Translation adjustment
–
Comprehensive income
–
Exercise of stock options 862,914
Common stock issued for
intangible asset
52,399
Tax benefit in connection
with nonqualified
stock options
–
BALANCE AT
DECEMBER 31,
2001
143,463,800
$ 2,417,000
–
–
–
–
(993,000)
11,000
–
1,435,000
–
–
–
–
10,000
5,000
–
–
1,450,000
–
–
–
–
–
8,000
–
–
$ 1,458,000
$ 48,218,000
–
–
–
–
993,000
2,672,000
6,237,000
58,120,000
–
–
–
–
4,458,000
16,284,000
3,850,000
20,736,000
103,448,000
–
–
–
–
–
4,081,000
746,000
14,842,000
$123,117,000
$ 27,967,000
13,889,000
–
–
–
–
–
–
41,856,000
21,003,000
–
–
–
–
–
–
–
62,859,000
34,419,000
–
–
–
–
–
–
–
$ 97,278,000
$ (2,372,000)
–
(7,000)
(2,160,000)
–
–
–
–
(4,539,000)
–
6,133,000
(1,995,000)
–
–
–
–
–
(401,000)
–
(3,606,000)
(1,296,000)
(3,575,000)
–
–
–
–
$ (8,878,000)
$ 76,230,000
13,889,000
(7,000)
(2,160,000)
11,722,000
–
2,683,000
6,237,000
96,872,000
21,003,000
6,133,000
(1,995,000)
25,141,000
4,468,000
16,289,000
3,850,000
20,736,000
167,356,000
34,419,000
(3,606,000)
(1,296,000)
(3,575,000)
25,942,000
4,089,000
746,000
14,842,000
$ 212,975,000
The accompanying notes are an integral part of these consolidated financial statements.